Rakesh K Mishra1, Wei Yang1, Jason Roy1, Amanda H Anderson1, Nisha Bansal1, Jing Chen1, Christopher DeFilippi1, Patrice Delafontaine1, Harold I Feldman1, Radhakrishna Kallem1, John W Kusek1, Claudia M Lora1, Sylvia E Rosas1, Alan S Go1, Michael G Shlipak2. 1. From the Division of Cardiology (R.K.M.) and Department of Epidemiology and Biostatistics (M.G.S.), University of California, San Francisco; Department of Biostatistics and Epidemiology (W.Y., J.R., A.H.A., H.I.F.), Renal, Electrolyte and Hypertension Division (R.K.), University of Pennsylvania, Philadelphia; Division of Nephrology, University of Washington, Seattle (N.B.); Departments of Nephrology and Hypertension (J.C.) and Medicine (P.D.), Tulane University, New Orleans, LA; Department of Medicine, University of Maryland, College Park (C.D.F.); National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD (J.W.K.); Division of Nephrology, University of Illinois, Champaign (C.M.L.); Joslin Diabetes Center and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (S.E.R.); Kaiser Permanente Division of Research, Oakland, CA (A.S.G.); and Department of Medicine, San Francisco Veterans Affairs Medical Center, CA (R.K.M., M.G.S.). 2. From the Division of Cardiology (R.K.M.) and Department of Epidemiology and Biostatistics (M.G.S.), University of California, San Francisco; Department of Biostatistics and Epidemiology (W.Y., J.R., A.H.A., H.I.F.), Renal, Electrolyte and Hypertension Division (R.K.), University of Pennsylvania, Philadelphia; Division of Nephrology, University of Washington, Seattle (N.B.); Departments of Nephrology and Hypertension (J.C.) and Medicine (P.D.), Tulane University, New Orleans, LA; Department of Medicine, University of Maryland, College Park (C.D.F.); National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD (J.W.K.); Division of Nephrology, University of Illinois, Champaign (C.M.L.); Joslin Diabetes Center and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (S.E.R.); Kaiser Permanente Division of Research, Oakland, CA (A.S.G.); and Department of Medicine, San Francisco Veterans Affairs Medical Center, CA (R.K.M., M.G.S.). michael.shlipak@ucsf.edu.
Abstract
BACKGROUND: Chronic kidney disease is a risk factor for heart failure (HF). Patients with chronic kidney disease without diagnosed HF have an increased burden of symptoms characteristic of HF. It is not known whether these symptoms are associated with occurrence of new onset HF. METHODS AND RESULTS: We studied the association of a modified Kansas City Cardiomyopathy Questionnaire with newly identified cases of hospitalized HF among 3093 participants enrolled in the Chronic Renal Insufficiency Cohort (CRIC) Study who did not report HF at baseline. The annually updated Kansas City Cardiomyopathy Questionnaire score was categorized into quartiles (Q1-4) with the lower scores representing the worse symptoms. Multivariable-adjusted repeated measure logistic regression models were adjusted for demographic characteristics, clinical risk factors for HF, N-terminal probrain natriuretic peptide level and left ventricular hypertrophy, left ventricular systolic and diastolic dysfunction. Over a mean (±SD) follow-up period of 4.3±1.6 years, there were 211 new cases of HF hospitalizations. The risk of HF hospitalization increased with increasing symptom quartiles; 2.62, 1.85, 1.14, and 0.74 events per 100 person-years, respectively. The median number of annual Kansas City Cardiomyopathy Questionnaire assessments per participant was 5 (interquartile range, 3-6). The annually updated Kansas City Cardiomyopathy Questionnaire score was independently associated with higher risk of incident HF hospitalization in multivariable-adjusted models (odds ratio, 3.30 [1.66-6.52]; P=0.001 for Q1 compared with Q4). CONCLUSIONS: Symptoms characteristic of HF are common in patients with chronic kidney disease and are associated with higher short-term risk for new hospitalization for HF, independent of level of kidney function, and other known HF risk factors.
BACKGROUND:Chronic kidney disease is a risk factor for heart failure (HF). Patients with chronic kidney disease without diagnosed HF have an increased burden of symptoms characteristic of HF. It is not known whether these symptoms are associated with occurrence of new onset HF. METHODS AND RESULTS: We studied the association of a modified Kansas City Cardiomyopathy Questionnaire with newly identified cases of hospitalized HF among 3093 participants enrolled in the Chronic Renal Insufficiency Cohort (CRIC) Study who did not report HF at baseline. The annually updated Kansas City Cardiomyopathy Questionnaire score was categorized into quartiles (Q1-4) with the lower scores representing the worse symptoms. Multivariable-adjusted repeated measure logistic regression models were adjusted for demographic characteristics, clinical risk factors for HF, N-terminal probrain natriuretic peptide level and left ventricular hypertrophy, left ventricular systolic and diastolic dysfunction. Over a mean (±SD) follow-up period of 4.3±1.6 years, there were 211 new cases of HF hospitalizations. The risk of HF hospitalization increased with increasing symptom quartiles; 2.62, 1.85, 1.14, and 0.74 events per 100 person-years, respectively. The median number of annual Kansas City Cardiomyopathy Questionnaire assessments per participant was 5 (interquartile range, 3-6). The annually updated Kansas City Cardiomyopathy Questionnaire score was independently associated with higher risk of incident HF hospitalization in multivariable-adjusted models (odds ratio, 3.30 [1.66-6.52]; P=0.001 for Q1 compared with Q4). CONCLUSIONS: Symptoms characteristic of HF are common in patients with chronic kidney disease and are associated with higher short-term risk for new hospitalization for HF, independent of level of kidney function, and other known HF risk factors.
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: J S Gottdiener; A M Arnold; G P Aurigemma; J F Polak; R P Tracy; D W Kitzman; J M Gardin; J E Rutledge; R C Boineau Journal: J Am Coll Cardiol Date: 2000-05 Impact factor: 24.094
Authors: Rakesh K Mishra; Yongmei Li; Christopher DeFilippi; Michael J Fischer; Wei Yang; Martin Keane; Jing Chen; Jiang He; Radhakrishna Kallem; Edward J Horwitz; Mohammad Rafey; Dominic S Raj; Alan S Go; Michael G Shlipak Journal: Am J Kidney Dis Date: 2013-01-04 Impact factor: 8.860
Authors: Linda F Fried; Michael G Shlipak; Casey Crump; Anthony J Bleyer; John S Gottdiener; Richard A Kronmal; Lewis H Kuller; Anne B Newman Journal: J Am Coll Cardiol Date: 2003-04-16 Impact factor: 24.094
Authors: Stacie A Luther; Peter A McCullough; Edward P Havranek; John S Rumsfeld; Philip G Jones; Paul A Heidenreich; Eric D Peterson; Saif S Rathore; Harlan M Krumholz; William S Weintraub; John A Spertus; Frederick A Masoudi Journal: J Card Fail Date: 2005-08 Impact factor: 5.712
Authors: Paul A Heidenreich; John A Spertus; Philip G Jones; William S Weintraub; John S Rumsfeld; Saif S Rathore; Eric D Peterson; Frederick A Masoudi; Harlan M Krumholz; Edward P Havranek; Mark W Conard; Randall E Williams Journal: J Am Coll Cardiol Date: 2006-01-26 Impact factor: 24.094
Authors: Peter Wohlfahrt; Dominik Jenča; Josef Stehlik; Vojtěch Melenovský; Jolana Mrázková; Vladimír Staněk; Jiří Kettner; Marek Šramko; Michael Želízko; Věra Adámková; Jan Piťha; Josef Kautzner Journal: Clin Res Cardiol Date: 2022-03-18 Impact factor: 5.460
Authors: Ke Wang; Michelle Nguyen; Yan Chen; Andrew N Hoofnagle; Jessica O Becker; Leila R Zelnick; John Kundzins; Anne Goodling; Jonathan Himmelfarb; Bryan Kestenbaum Journal: Clin J Am Soc Nephrol Date: 2020-03-09 Impact factor: 8.237
Authors: Samson Okello; Fardous Charles Abeya; Boniface Amanee Elias Lumori; Suzan Joan Akello; Christopher Charles Moore; Brian H Annex; Andrew J Buda Journal: BMC Cardiovasc Disord Date: 2018-12-12 Impact factor: 2.298
Authors: Sri Lekha Tummalapalli; Leila R Zelnick; Amanda H Andersen; Robert H Christenson; Christopher R deFilippi; Rajat Deo; Alan S Go; Jiang He; Bonnie Ky; James P Lash; Stephen L Seliger; Elsayed Z Soliman; Michael G Shlipak; Nisha Bansal Journal: J Am Heart Assoc Date: 2020-06-24 Impact factor: 5.501